Trial Profile
Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in 11-12 Year Old Children, Previously Vaccinated With DTPa-HBV-IPV/Hib Vaccine in Study 217744/031
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jul 2023
Price :
$35
*
At a glance
- Drugs Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa) (Primary) ; Hepatitis B vaccine recombinant; Hib-DTaP-poliovirus vaccine
- Indications Hepatitis B
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 10 Dec 2010 Planned end date changed from 1 Dec 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.
- 10 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.